The power of SWATH® Acquisition with SCIEX TripleTOF® system technology enabled industrialized proteomics and now promises similar revolution for other application areas
Their research gives oncologists a better shot at overcoming the problems of drug resistance, toxicity to patients, and a host of other barriers to consistently achieving successful gene therapy for cancer
An international study was launched when researchers found that another inhibitor for advanced cancers, called OTS167, had a negative outcome in a clinical trial
Early phase drug discovery research requires the highest level of accurate and reproducible testing in order to give you the proof to move confidently forward